The recent shift in the UK's regulatory landscape, marked by the adoption of the International Recognition Procedure (IRP) by the Medicines and Health...
At Navitas Life Sciences, we are at the forefront of providing comprehensive regulatory services that ensure compliance, accelerate time-to-market, an...
How Navitas Life Sciences grew to be a Strategic Partner for Top Pharma across the World Clinical trials are the backbone of modern medical advancemen...
The global clinical trials market, valued at USD 80.7 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. This expansion highlights the critical importance of selecting the right Contract Research Organization (CRO) to manage efficient and compliant clinical trials. In our latest blog, we discus...
By reimagining regulatory submission strategies with artificial intelligence in regulatory affairs, pharmaceutical companies can expedite timelines and boost their chances of successful product approvals. To accelerate the market entry of new products, there is a need to increasingly focus on regulatory submissions as a critical area for developing...
At Navitas Life Sciences, we believe in not just advancing the frontiers of pharmaceutical sciences but also in giving back to society and academia. Dr Latika Sharma, MBBS., MD, our PV Networks Lead, led an insightful seminar as a part of clinical research & pharmacovigilance training on “Pharmacovigilance: Trends, Opportunities & Ch...
In the fight against counterfeit medicines, the stakes are incredibly high. Counterfeit drugs pose significant threats to public health worldwide, with far-reaching consequences, especially in regions with limited regulatory oversight. At Navitas Life Sciences, we are dedicated to addressing these challenges head-on. Recently, Dr. Philipp Hofmann, ...
There is an increasing focus on diversity in clinical trials, which is crucial for providing essential data on the safety and efficacy of new treatments before they are approved for widespread use. However, a significant issue plaguing the clinical trial process is the underrepresentation of older adults. This lack of age diversity in clinical tria...
Data management services are a critical component of any clinical trial's success. For clinical research organizations, the integration of advanced clinical data management services can make or break the efficiency and reliability of their studies. Understanding the meaning of clinical data management is essential, as it encompasses the collection,...
The International Clinical Trials Day brought to the fore the significance of Clinical trials in supporting medical advancements. Clinical Trials provide the necessary data to bring new treatments to the market. Contract Research Organizations (CROs) play a pivotal role in this process, offering comprehensive support for the planning, execution, an...
“Congratulations on the PMDA approval, that is a huge accomplishment. The submission would never have been possible without your hard work and dedication. Thank you.” Senior Director, Biostatistics Programming, Global Biopharmaceutical Company talking about our Global FSP solutions. Expertise, hard work, dedication, and high quality h...
Patient-centric clinical trials, which are likely to be more efficient, productive, and engaging with patients and their needs, are at the forefront of Navitas Life Sciences' approach. The Society for Clinical Trials (SCT) 2024 theme, 'It takes a village: Patient-centered partnerships in clinical trials,' resonates deeply with us. As one of the lea...
In clinical research, efficiency and quality are key. As the industry continues to grow, Functional Service Provider (FSP) models are gaining popularity for their ability to streamline operations and provide specialized services. As a leading CRO, Navitas Life Sciences also offers robust FSP services that can enhance the efficiency and outcomes of ...